| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ATYR sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 779.1K | $386.7K | - | |
| CEO | 153.6K | $149.9K | - | |
| CFO | 37.3K | $36.4K | - | |
| Other | 33.1K | $32.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2018 | Mendlein John50 | Director | Buy | 245,000 | $0.42 | $103,247.00 | +66.1% | |
| Nov 26, 2018 | Schimmel Paul51 | Director | Buy | 147,225 | $0.54 | $79,795.95 | +20.0% | |
| Sep 20, 2018 | Broadfoot Jill Marie63 | Chief Financial Officer | Buy | 64,000 | $0.83 | $52,854.80 | +246.2% | |
| Sep 14, 2018 | Broadfoot Jill Marie63 | Chief Financial Officer | Buy | 26,000 | $0.73 | $19,055.40 | New | |
| Sep 4, 2018 | Schimmel Paul51 | Director | Buy | 42,749 | $0.74 | $31,461.07 | +6.2% | |
| Aug 30, 2018 | Schimmel Paul51 | Director | Buy | 164,411 | $0.74 | $121,573.38 | +31.1% | |
| May 18, 2018 | Schimmel Paul51 | Director | Buy | 150,000 | $1.00 | $149,445.00 | +39.7% | |
| May 16, 2018 | Ecor1 Capital Fund Qualified, L.P. | 10% Owner | Sell | 3,209,316 | $0.93 | $2,999,055.65 | -100% | |
| Feb 8, 2018 | Blake John T | Senior Vice President, Finance | Sale+OE | 1,402 | $3.40 | $4,766.80 | -42.1% | |
| Feb 8, 2018 | Amanullah Ashraf | See Remarks | Sale+OE | 1,402 | $3.40 | $4,766.80 | -42.1% |